Literature DB >> 26235512

Incidence of Merkel cell carcinoma in Olmsted County, Minnesota: a population-based study.

Michael B Chang1, Amy L Weaver2, Jerry D Brewer3.   

Abstract

BACKGROUND: Merkel cell carcinoma (MCC) is a rare, aggressive, often cutaneous malignancy. The incidence has been estimated from national registries in the USA and elsewhere, and data indicate variations depending on the region studied. The objective of this study was to determine the incidence of MCC in Olmsted County (MN, USA).
METHODS: Using the Rochester Epidemiology Project, which contains health records for all the residents of Olmsted County, we retrospectively reviewed the records for all cases of MCC from 1976 to 2011.
RESULTS: The overall annual age- and sex-adjusted incidence of MCC in Olmsted County during 1976-2011 was 0.35 per 100,000 person-years (95% CI, 0.14-0.57). The incidence tended to be higher among men than women with 0.69 per 100,000 (95% CI, 0.24-1.14) and 0.10 per 100,000 (95% CI, 0-0.24), respectively.
CONCLUSIONS: These data are within the range of previous MCC incidence reports, and the incidence of MCC in Olmsted County is consistent with rates reported in the remainder of the USA.
© 2015 The International Society of Dermatology.

Entities:  

Mesh:

Year:  2015        PMID: 26235512      PMCID: PMC4706489          DOI: 10.1111/ijd.12812

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  22 in total

1.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Cynthia L Leibson; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007.

Authors:  B A Reichgelt; O Visser
Journal:  Eur J Cancer       Date:  2010-12-06       Impact factor: 9.162

Review 3.  Merkel cell carcinoma: critical review with guidelines for multidisciplinary management.

Authors:  Christopher K Bichakjian; Lori Lowe; Christopher D Lao; Howard M Sandler; Carol R Bradford; Timothy M Johnson; Sandra L Wong
Journal:  Cancer       Date:  2007-07-01       Impact factor: 6.860

4.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

5.  Merkel cell carcinoma: incidence, mortality, and risk of other cancers.

Authors:  Jeanette Kaae; Anne V Hansen; Robert J Biggar; Heather A Boyd; Patrick S Moore; Jan Wohlfahrt; Mads Melbye
Journal:  J Natl Cancer Inst       Date:  2010-04-27       Impact factor: 13.506

6.  Prognostic factors in Merkel cell carcinoma: analysis of 240 cases.

Authors:  Tina I Tarantola; Laura A Vallow; Michele Y Halyard; Roger H Weenig; Karen E Warschaw; Travis E Grotz; James W Jakub; Randall K Roenigk; Jerry D Brewer; Amy L Weaver; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2012-11-27       Impact factor: 11.527

Review 7.  A comprehensive review of the treatment of Merkel cell carcinoma.

Authors:  Tony Y Eng; Melisa G Boersma; Clifton D Fuller; Virginia Goytia; William E Jones; Melissa Joyner; Dominic D Nguyen
Journal:  Am J Clin Oncol       Date:  2007-12       Impact factor: 2.339

8.  Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

Authors:  R Moll; A Löwe; J Laufer; W W Franke
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

Review 9.  Unknown primary Merkel cell carcinoma: 23 new cases and a review.

Authors:  Tina I Tarantola; Laura A Vallow; Michele Y Halyard; Roger H Weenig; Karen E Warschaw; Amy L Weaver; Randall K Roenigk; Jerry D Brewer; Clark C Otley
Journal:  J Am Acad Dermatol       Date:  2012-11-19       Impact factor: 11.527

Review 10.  Clinical recognition, diagnosis, and staging of merkel cell carcinoma, and the role of the multidisciplinary management team.

Authors:  Amod A Sarnaik; Mary H Lien; Paul Nghiem; Christopher K Bichakjian
Journal:  Curr Probl Cancer       Date:  2010 Jan-Feb       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.